The Use of Naltrexone in Low Doses Beyond the Approved Indication [Internet]

Report from Norwegian Knowledge Centre for the Health Services
April 2015
https://pubmed.ncbi.nlm.nih.gov/28510411/

Low-Dose Naltrexone in Diseases' Treatment: Global Review

Could Low-Dose Naltrexone be an Effective Treatment for Hailey-Hailey Disease?

Integ Biomed Sci
19 July 2016
https://www.gratisoa.org/journals/index.php/MML/article/view/1293/957

Acquired immunodeficiency syndrome: molecular biology and its therapeutic intervention (review)

In Vivo
Mar-Apr 1989
https://www.ncbi.nlm.nih.gov/pubmed/2519841

Efficacy of low dose naltrexone as an immune stabilizing agent for the treatment of HIV/AIDS
      B. Bihari

AIDS Patient Care
February 1995
https://pubmed.ncbi.nlm.nih.gov/11361353/

No summary available.

Effectiveness Study Low-Dose Naltrexone Versus ARV's for HIV+ (Study)

Exp Clin Psychopharmacol
2010
https://clinicaltrials.gov/ct2/show/NCT01174914

Bernard Bihari, MD: Low-Dose Naltrexone for normalizing immune system function

Altern Ther Health Med
05 November 2013
http://todayspractitioner.com/wp-content/uploads/2013/10/Bernard-Bihari-MD-Low-dose-Naltrexone-for-Normalizing-Immune-System-Function-athm_19_2_bihari_56_65.pdf

Low Dose Naltrexone in the Treatment of HIV Infection
      by Bernard Bihari, MD

Low Dose Naltrexone (LDN)
September 1996
https://www.lowdosenaltrexone.org/ldn_hiv_1996.htm

Brief summary of the history of the development of low dose naltrexone as an immune-enhancing agent in the treatment of HIV/AIDS

Keywords: low dose naltrexone, HIV, AIDs, placebo-controlled trial, endorphins, immune system, beta endorphin, metenkephalin, opportunistic infections

The Uses of Low-Dose Naltrexone in Clinical Practice

BMJ Case Reports
January 2018
https://www.researchgate.net/publication/328997819_Issue_4_The_Uses_of_Low-Dose_Naltrexone_in_Clinical_Practice

Nasha Winters, ND - The Low Down on LDN (2017 Conference) (LDN, low dose naltrexone)

In this presentation Dr Winters talks about the history of Low Dose Naltrexone (LDN) and recounts its remarkable story in terms of treatment in HIV patients and the positive effects it can have on immunodeficient patients.